HMB Cerebral Palsy Pilot Study

Status unconfirmed · Not applicable

Conditions studied: Cerebral Palsy

In brief

This is a pilot study of β-hydroxy-β-methylbutyrate (HMB) + Vitamin D3 supplementation in adolescents with cerebral palsy. The primary objective is to quantify safety, compliance, and acceptability of daily combined HMB + Vitamin D3 supplementation for 12 weeks in adolescents with CP. The secondary objective is to quantify changes in lower extremity muscle mass, strength, and functional mobility after daily combined HMB + Vitamin D3 supplementation for 12 weeks.

Key facts

Study ID
NCT05384951
Run by
Gillette Children's Specialty Healthcare
People needed
7
Starts
2022-05-15
Expected to finish
2024-05-31
Last updated by the study team
2024-02-22

Who can join

Age: 13 and older, up to 17. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.